» Articles » PMID: 22777340

A Prospective Study of Cigarette Smoking and the Risk of Inflammatory Bowel Disease in Women

Overview
Specialty Gastroenterology
Date 2012 Jul 11
PMID 22777340
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Long-term data on the influence of cigarette smoking, especially cessation, on the risk of Crohn's disease (CD) and ulcerative colitis (UC) are limited.

Methods: We conducted a prospective study of 229,111 women in the Nurses' Health Study (NHS) and Nurses' Health Study II (NHS II). Biennially, we collected updated data on cigarette smoking, other risk factors, and diagnoses of CD or UC confirmed by medical record review.

Results: Over 32 years in NHS and 18 years in NHS II, we documented 336 incident cases of CD and 400 incident cases of UC. Compared with never smokers, the multivariate hazard ratio (HR) of CD was 1.90 (95% confidence interval (CI), 1.42-2.53) among current smokers and 1.35 (95% CI, 1.05-1.73) among former smokers. Increasing pack-years was associated with increasing risk of CD (Ptrend < 0.0001), whereas smoking cessation was associated with an attenuation of risk. By contrast, the multivariate HR of UC was 0.86 (95% CI, 0.61-1.20) among current smokers and 1.56 (95% CI, 1.26-1.93) among former smokers. The risk of UC was significantly increased within 2-5 years of smoking cessation (HR, 3.06; 95% CI, 2.00-4.67) and remained persistently elevated over 20 years.

Conclusions: Current smoking is associated with an increased risk of CD, but not UC. By contrast, former smoking is associated with an increased risk of UC, with risk persisting over two decades after cessation.

Citing Articles

Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.

Calvez V, Puca P, Di Vincenzo F, Del Gaudio A, Bartocci B, Murgiano M Biomedicines. 2025; 13(2).

PMID: 40002718 PMC: 11853239. DOI: 10.3390/biomedicines13020305.


Influence of biological sex in inflammatory bowel diseases.

Tshikudi D, Bernstein C, Mishra S, Ghia J, Armstrong H Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39962330 DOI: 10.1038/s41575-025-01038-y.


Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?.

Melhem H, Hendrik Niess J Int J Mol Sci. 2024; 25(15).

PMID: 39126102 PMC: 11313654. DOI: 10.3390/ijms25158534.


The Role of Environmental and Nutritional Factors in the Development of Inflammatory Bowel Diseases: A Case-Control Study.

Serrano-Fernandez V, Laredo-Aguilera J, Navarrete-Tejero C, Molina-Gallego B, Lopez-Fernandez-Roldan A, Carmona-Torres J Nutrients. 2024; 16(15).

PMID: 39125343 PMC: 11313778. DOI: 10.3390/nu16152463.


The Function of Necroptosis and Its Treatment Target in IBD.

Akanyibah F, Zhu Y, Jin T, Ocansey D, Mao F, Qiu W Mediators Inflamm. 2024; 2024:7275309.

PMID: 39118979 PMC: 11306684. DOI: 10.1155/2024/7275309.


References
1.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

2.
Moum B, Vatn M, Ekbom A, Fausa O, Aadland E, Lygren I . Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion. 1995; 56(5):377-81. DOI: 10.1159/000201262. View

3.
Mahid S, Minor K, Soto R, Hornung C, Galandiuk S . Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006; 81(11):1462-71. DOI: 10.4065/81.11.1462. View

4.
Baumgart D, Carding S . Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369(9573):1627-40. DOI: 10.1016/S0140-6736(07)60750-8. View

5.
Logan R, Edmond M, Somerville K, Langman M . Smoking and ulcerative colitis. Br Med J (Clin Res Ed). 1984; 288(6419):751-3. PMC: 1444645. DOI: 10.1136/bmj.288.6419.751. View